• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cirrhosis and intestinal B-cell lymphoma: two entities that are rarely associated with celiac disease.

作者信息

Duman Ali Erkan, Oğütmen Koç Deniz, Korkmaz Uğur, Tohumcu Ayşegül, Celebi Altay, Sentürk Omer, Hülagü Saadettin, Erçin Cengiz

出版信息

Turk J Gastroenterol. 2013;24(2):192-4. doi: 10.4318/tjg.2013.0478.

DOI:10.4318/tjg.2013.0478
PMID:23934474
Abstract
摘要

相似文献

1
Cirrhosis and intestinal B-cell lymphoma: two entities that are rarely associated with celiac disease.肝硬化与肠道B细胞淋巴瘤：两种很少与乳糜泻相关的疾病。
Turk J Gastroenterol. 2013;24(2):192-4. doi: 10.4318/tjg.2013.0478.
2
Rituximab and bendamustine in patients with CD20+ diffuse large B-cell lymphoma not eligible for cyclophosphamide, doxorubicin, vincristine and prednisone-like chemotherapy.利妥昔单抗与苯达莫司汀用于不符合环磷酰胺、多柔比星、长春新碱和泼尼松样化疗条件的CD20+弥漫性大B细胞淋巴瘤患者。
Leuk Lymphoma. 2012 Nov;53(11):2290-2. doi: 10.3109/10428194.2012.682311. Epub 2012 May 22.
3
High-risk diffuse large B-cell lymphoma: can we do better than rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone?高危弥漫性大B细胞淋巴瘤：我们能否比利妥昔单抗、环磷酰胺、阿霉素、长春新碱和泼尼松做得更好？
Leuk Lymphoma. 2013 Dec;54(12):2575-6. doi: 10.3109/10428194.2013.796059. Epub 2013 May 21.
4
Long-term follow-up of patients with HIV-related diffuse large B-cell lymphomas treated in a phase II study with rituximab and CHOP.在一项使用利妥昔单抗和CHOP方案的II期研究中接受治疗的HIV相关弥漫性大B细胞淋巴瘤患者的长期随访
Br J Haematol. 2012 Jun;157(5):637-9. doi: 10.1111/j.1365-2141.2012.09046.x. Epub 2012 Feb 7.
5
BEACOPP escalated and rituximab in the treatment of Hodgkin lymphoma occurring concurrently with diffuse large B-cell non-Hodgkin lymphoma.BEACOPP方案强化治疗联合利妥昔单抗用于治疗同时发生弥漫性大B细胞非霍奇金淋巴瘤的霍奇金淋巴瘤。
Leuk Lymphoma. 2013 Sep;54(9):2081-2. doi: 10.3109/10428194.2012.762514. Epub 2013 Feb 1.
6
Complete remission of primary cutaneous intravascular large B-cell lymphoma with R-CHOP followed by rituximab monotherapy.采用R-CHOP方案治疗原发性皮肤血管内大B细胞淋巴瘤，随后使用利妥昔单抗单药治疗实现完全缓解。
Dermatol Ther. 2017 Jul;30(4). doi: 10.1111/dth.12499. Epub 2017 May 16.
7
Intravascular Large B-Cell Lymphoma of the Gallbladder.胆囊血管内大B细胞淋巴瘤
Turk J Haematol. 2018 May 25;35(2):145-146. doi: 10.4274/tjh.2017.0276. Epub 2018 Feb 2.
8
Occurrence of sarcoidosis after chemotherapy for non-Hodgkin lymphoma.非霍奇金淋巴瘤化疗后结节病的发生
Korean J Intern Med. 2016 May;31(3):605-7. doi: 10.3904/kjim.2014.305. Epub 2016 Mar 12.
9
Genetic polymorphism at as a predictor for rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone efficacy in patients with diffuse large B-cell lymphoma.作为弥漫性大B细胞淋巴瘤患者利妥昔单抗、环磷酰胺、阿霉素、长春新碱和泼尼松疗效预测指标的基因多态性
Haematologica. 2017 May;102(5):e199-e202. doi: 10.3324/haematol.2016.159087. Epub 2017 Feb 2.
10
Primary diffuse large B-Cell lymphoma of the prostate presenting with urinary retention and dyschezia for which rituximab-combined CHOP therapy was effective-a case presentation.以尿潴留和排便困难为表现的原发性前列腺弥漫性大B细胞淋巴瘤，利妥昔单抗联合CHOP方案治疗有效——病例报告
Gan To Kagaku Ryoho. 2012 Nov;39(11):1733-5.

引用本文的文献

1
Fatty liver and celiac disease: Why worry?脂肪肝与乳糜泻：为何担忧？
World J Hepatol. 2023 May 27;15(5):666-674. doi: 10.4254/wjh.v15.i5.666.
2
Celiac disease screening in patients with cryptogenic cirrhosis.对隐源性肝硬化患者进行乳糜泻筛查。
World J Gastroenterol. 2023 Jan 14;29(2):410-412. doi: 10.3748/wjg.v29.i2.410.
3
Epstein-Barr Virus-positive Intestinal Diffuse Large B-cell Lymphoma in a Japanese Patient with Celiac Disease: First Reported Case and a Literature Review.肠黏膜相关弥漫大 B 细胞淋巴瘤合并乳糜泻一例并文献复习
Intern Med. 2022 Feb 1;61(3):329-334. doi: 10.2169/internalmedicine.7876-21. Epub 2021 Jul 30.
4
To screen or not to screen? Celiac antibodies in liver diseases.筛查还是不筛查？肝脏疾病中的乳糜泻抗体。
World J Gastroenterol. 2017 Feb 7;23(5):776-791. doi: 10.3748/wjg.v23.i5.776.